Annals of internal medicine
- 
    Comment Randomized Controlled TrialIn active UC, upadacitinib induced and maintained remission.Danese S, Vermeire S, Zhou W, et al. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials. Lancet. 2022;399:2113-28. 35644166. 
- 
    
    Rhythm control is associated with lower risk for adverse cardiovascular outcomes compared with usual care among patients recently diagnosed with atrial fibrillation (AF) with a CHA2DS2-VASc score of approximately 2 or greater in EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial). ⋯ The Ministry of Health and Welfare and the Ministry of Food and Drug Safety, Republic of Korea.